Literature DB >> 18633615

The application of conventional cytogenetics, FISH, and RT-PCR to detect genetic changes in 70 children with ALL.

Krystyna Soszynska1, Barbara Mucha, Robert Debski, Katarzyna Skonieczka, Ewa Duszenko, Andrzej Koltan, Mariusz Wysocki, Olga Haus.   

Abstract

We investigated bone marrow cells of 70 acute lymphoblastic leukemia children by conventional cytogenetics (CC), fluorescence in situ hybridization (FISH), and reverse transcription polymerase chain reaction (RT-PCR) methods. CC and RT-PCR for fusion genes BCR/ABL, MLL/AF4, E2A/PBX1, TEL/AML1 were performed at diagnosis in each patient. FISH was performed to verify the presence of fusion genes and MLL rearrangements and to estimate the percentage of abnormal cells. Karyotypes were obtained in 59 (84%) of 70 cases. Thirty-five (59%) of 59 cases revealed chromosome aberrations. Hyperdiploidy>50 chromosomes was present in nine cases, hyperdiploidy 47-50 chromosomes in six, pseudodiploidy in 15, and hypodiploidy in five. BCR/ABL was present in two cases, PBX1/E2A in two, and TEL/AML1 in 14. MLL/AF4 was not found, but the rearrangements of MLL gene were present in five children. The addition of RT-PCR and FISH to CC was of the utmost importance. One of two Ph translocations and one of two t(1;19) were first revealed by RT-PCR. Moreover, FISH showed the percentage of TEL/AML1(+) cells that turned to be an important prognostic factor. The outcome was the best for the children with hyperdiploidy>50 chromosomes without structural changes. It was also good for those with TEL/AML1 present in >or=80% of cells without chromosome aberrations. The presence of pseudodiploidy correlated with poor outcome. The outcome for patients with t(9;22)-BCR/ABL or 11q23-MLL rearrangement was the worst in study group. The presence of BCR/ABL caused eight times increase of risk of death; MLL rearrangements caused 12 times increase.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18633615     DOI: 10.1007/s00277-008-0540-6

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  4 in total

1.  Evaluation of cytogenetic and molecular markers with MTX-mediated toxicity in pediatric acute lymphoblastic leukemia patients.

Authors:  Ravi Ramalingam; Harpreet Kaur; Julius Xavier Scott; Latha M Sneha; Ganeshprasad Arunkumar; Arathi Srinivasan; Solomon F D Paul
Journal:  Cancer Chemother Pharmacol       Date:  2022-02-14       Impact factor: 3.333

2.  Cytogenetic and Molecular Findings in Children with Acute Lymphoblastic Leukemia: Experience of a Single Institution in Argentina.

Authors:  Mariela C Coccé; Cristina N Alonso; Jorge G Rossi; Andrea R Bernasconi; Maria A Rampazzi; Maria S Felice; Patricia L Rubio; Silvia Eandi Eberle; Adriana Medina; Marta S Gallego
Journal:  Mol Syndromol       Date:  2015-10-07

3.  High Throughput FISH Analysis: A New, Sensitive Option For Evaluation of Hematological Malignancies.

Authors:  Hakan Savlı; Nilüfer Uzülmez; Zeynep Ilkay; Duygu Yavuz; Deniz Sünnetçi; Abdullah Hacıhanifioğlu; Naci Cine
Journal:  Turk J Haematol       Date:  2013-06-05       Impact factor: 1.831

4.  Comparison of Diagnostic Yield of a FISH Panel Against Conventional Cytogenetic Studies for Hematological Malignancies: A South Indian Referral Laboratory Analysis Of 201 Cases

Authors:  Vishal Ashok; Ramya Ranganathan; Smitha Chander; Sharat Damodar; Sunil Bhat; Nataraj K S; Satish Kumar A; Sachin Suresh Jadav; Mahesh Rajashekaraiah; Sundareshan T S
Journal:  Asian Pac J Cancer Prev       Date:  2017-12-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.